×
About 13,630 results

ALLMedicine™ Gastroesophageal Reflux Disease Center

Research & Reviews  3,547 results

Prevalence and comorbidities of bronchiolitis in adults: A population-based study in So...
https://doi.org/10.1097/MD.0000000000029551
Medicine Jeong JS, Kim JS et. al.

Jun 28th, 2022 - Bronchiolitis generally refers to inflammation and/or fibrosis of the non-cartilaginous small airways located approximately from the 8th airway generation down to the terminal and respiratory bronchioles. In contrast to young children, the frequen...

Robotic Single Port (SP) Anti-Reflux Surgery: Initial worldwide experience of two cases...
https://doi.org/10.1002/rcs.2437
The International Journal of Medical Robotics + Computer ... Cubisino A, Dreifuss NH et. al.

Jun 28th, 2022 - To date, no anti-reflux operations have been reported with the new daVinci Single-Port (SP) robotic platform. We aimed to describe this novel surgical approach and evaluate its safety and feasibility. All robotic SP operations were performed under...

Impact of esophageal mucosal permeability markers on provocation-induced esophageal ref...
https://doi.org/10.14814/phy2.15366
Physiological Reports; Jadcherla SR, Helmick R et. al.

Jun 28th, 2022 - Esophageal distal baseline impedance (DBI) is an indicator of mucosal integrity; lower values suggest increased permeability. Aims were to characterize the (1) effect of DBI category (<900 Ω, 900-2000 Ω, and >2000 Ω) on sensory-motor characteristi...

Acute oxygen desaturation characterizes pulmonary aspiration in patients with gastroeso...
https://doi.org/10.14814/phy2.15367
Physiological Reports; Weerasinghe DP, Burton L et. al.

Jun 28th, 2022 - The aim of this study was to characterise pulmonary aspiration of refluxate in patients with gastroesophageal reflux disease (GORD) and laryngopharyngeal reflux (LPR) by continuous pulse oximetry (SpO2) during the supine phase of a scintigraphic r...

A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporate...
https://doi.org/10.1002/psp4.12839
CPT: Pharmacometrics & Systems Pharmacology; Chung TK, Lee HA et. al.

Jun 25th, 2022 - YH4808 is a novel potassium-competitive acid blocker that is under clinical development to treat patients with gastroesophageal reflux disease and peptic ulcer diseases. In this study, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of ...

see more →

Guidelines  21 results

AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Managem...
https://doi.org/10.1016/j.cgh.2022.01.025
Clinical Gastroenterology and Hepatology : the Official C... Yadlapati R, Gyawali CP et. al.

Feb 6th, 2022 - As many as one-half of all patients with suspected gastroesophageal reflux disease (GERD) do not derive benefit from acid suppression. This review outlines a personalized diagnostic and therapeutic approach to GERD symptoms. The Best Practice Advi...

ACR Appropriateness Criteria® Chronic Cough.
https://doi.org/10.1016/j.jacr.2021.08.007
Journal of the American College of Radiology : JACR; , Kuzniewski CT et. al.

Nov 20th, 2021 - Chronic cough is defined by a duration lasting at least 8 weeks. The most common causes of chronic cough include smoking-related lung disease, upper airway cough syndrome, asthma, gastroesophageal reflux disease, and nonasthmatic eosinophilic bron...

ACR Appropriateness Criteria® Epigastric Pain.
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

Screening for Lung Cancer
https://www.aafp.org/afp/2021/0700/p79.html
American Family Physician; Tracer H, Pierre J.

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing.
https://doi.org/10.14309/ajg.0000000000000734
The American Journal of Gastroenterology; Gyawali CP, Carlson DA et. al.

Aug 10th, 2020 - Esophageal symptoms are common and may indicate the presence of gastroesophageal reflux disease (GERD), structural processes, motor dysfunction, behavioral conditions, or functional disorders. Esophageal physiologic tests are often performed when ...

see more →

Drugs  726 results see all →

Clinicaltrials.gov  471 results

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
https://clinicaltrials.gov/ct2/show/NCT05343364

Jun 24th, 2022 - This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(...

Efficacy and Safety of Thread Embedding Acupuncture in Treating Gastroesophageal Reflux Disease
https://clinicaltrials.gov/ct2/show/NCT05353933

Jun 21st, 2022 - Patients with GERD diagnosed based on the GerdQ score who meet the inclusion criteria and do not meet the exclusion criteria will be included in the study. After randomization, patients will be divided into 2 groups: control group and intervention...

ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
https://clinicaltrials.gov/ct2/show/NCT05425771

Jun 21st, 2022 - Prospective, non-controlled, monocentric pilot study in patients with therapy-refractory reflux symptoms under proton pump inhibitor (PPI) therapy or intolerance of the necessary therapy or rapid recurrence of the symptoms with tapering therapy. T...

A Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children
https://clinicaltrials.gov/ct2/show/NCT02616302

Jun 16th, 2022 - The drug being tested in this study is called dexlansoprazole. Dexlansoprazole is being tested to treat children aged 2 to 11 years who have nonerosive GERD. This study will look at the effectiveness and side effects of three different doses of de...

Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
https://clinicaltrials.gov/ct2/show/NCT04411823

Jun 16th, 2022 - Subjects will undergo an upper endoscopy with EndoFLIP before sleeve gastrectomy to measure parameters from endoscopy and EndoFLIP device to develop a prediction model for post-operative gastroesophageal reflux disease. Subjects will undergo a rep...

see more →

News  665 results

More Reflux After Sleeve Gastrectomy vs Gastric Bypass at 10 Years
https://www.medscape.com/viewarticle/976206

Jun 27th, 2022 - Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) each led to good and sustainable weight loss 10 years later, although reflux was more prevalent after SG, according to the Sleeve vs Bypass (SLEEVEPASS) randomized clinical trial. At 10 y...

Baclofen shows limited role in GERD
https://www.mdedge.com/internalmedicine/article/255658/gastroenterology/baclofen-shows-limited-role-gerd
Jim Kling

Jun 22nd, 2022 - A randomized clinical trial indicated that add-on baclofen may be of benefit to patients on adequate doses of proton pump inhibitors (PPI) with refractory gastroesophageal reflux disease (GERD). However, the benefit was limited to a subset of pati.

A guide to GERD, H pylori infection, and Barrett esophagus
https://www.mdedge.com/familymedicine/article/255367/gastroenterology/guide-gerd-h-pylori-infection-and-barrett-esophagus
MDedge Family Medicine; Megan Everson, MD, Alice M. Boshoven, MD et. al.

Jun 13th, 2022 - Three conditions seen in primary care—gastroesophageal reflux disease (GERD), Helicobacter pylori (H pylori) infection, and Barrett esophagus (BE)—evolve in a gastric acid environment and are treated in part through gastric acid suppression. While.

Esophageal cancer screening isn’t for everyone: Study
https://www.mdedge.com/internalmedicine/article/255263/gastroenterology/esophageal-cancer-screening-isnt-everyone-study
Brandon May

Jun 7th, 2022 - Endoscopic screening for esophageal adenocarcinoma (EAC), may not be a cost-effective strategy for all populations, possibly even leading to net harm in some, according to a comparative cost-effectiveness analysis. Several U.

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Treatment
https://www.medscape.com/viewarticle/909155

May 12th, 2022 - Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease. Although the cause of IPF is unknown, factors thought to increase an individual's risk of developing IPF include a history of smoking, gastroesophageal reflux diseas...

see more →

Patient Education  22 results see all →